ARTG 311431Ambulatory insulin infusion pump/blood glucose analyser system
ARTG ID: 311431 · Roche Diabetes Care Australia Pty Ltd · Roche Diabetes Care GmbH · Class IIb · Started November 12, 2018
Good Name: Roche Diabetes Care Australia Pty Ltd - Ambulatory insulin infusion pump/blood glucose analyser system
- Risk Class
- Class IIb
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 311431
- Start Date
- November 12, 2018
- Effective Date
- November 12, 2018
- Country
- Germany
- Address
- Sandhofer strasse 116, Mannheim, 68305
Intended for the subcutaneous continuous delivery of insulin via customizable hourly rates, for the management of diabetes mellitus in persons requiring insulin as prescribed by a physician.
Access comprehensive regulatory information for Ambulatory insulin infusion pump/blood glucose analyser system in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 311431 and sponsored by Roche Diabetes Care Australia Pty Ltd, manufactured by Roche Diabetes Care GmbH in Germany. The device registration started on November 12, 2018.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.